Latest filing published 11 Jun 2024 for ANI Pharmaceuticals INC, €329k.
Filing timeline
BuySaleInsider track record
James G. Marken: trading record in brief
James G. Marken (senior executive) discloses dealings in ANI Pharmaceuticals Inc to SEC (Form 4). In total, 64 filings cover trades dated from 19 June 2013 to 7 June 2024.
The open-market record consists of 10 sales worth €4.6M, with no purchase. Besides market trades, the filings include 45 share grants and 9 option exercises. Since January 2024: no purchases and 1 sale on the market.
The record was last updated on 11 June 2024 with an option exercise (€329k) in ANI Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James G. Marken
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,250 shares@ US$49.517.4% of flowCommon StockSEC:0001579587-24-000013:0
- 5,300 shares@ US$57.066.2% of flowCommon StockSEC:0001579587-24-000013:1
- 11,087 shares@ US$67.7015.5% of flowCommon StockSEC:0001579587-24-000013:2
- 2,799 shares@ US$66.963.9% of flowCommon StockSEC:0001579587-24-000011:0
- 3,653 shares@ US$69.585.3% of flowCommon StockSEC:0001579587-24-000009:0
- 2,034 shares@ US$66.712.0% of flowCommon StockSEC:0001579587-24-000006:1
- 24,338 shares@ US$66.3733.3% of flowCommon StockSEC:0001579587-24-000006:0
- 1,058 shares@ US$67.671.5% of flowCommon StockSEC:0001579587-24-000004:0
- 6,710 shares0Common StockSEC:0001579587-24-000002:1
- 10,066 shares0Common StockSEC:0001579587-24-000002:0
- 1,667 shares@ US$33.000.8% of flowCommon StockSEC:0001579587-23-000005:1
- 3,932 shares@ US$63.003.6% of flowCommon StockSEC:0001579587-23-000005:2
- 3,750 shares@ US$40.593.1% of flowCommon StockSEC:0001579587-23-000005:0
- 2,289 shares@ US$38.501.8% of flowCommon StockSEC:0001104659-23-044634:0
- 13,026 shares0Common StockSEC:0001104659-23-041737:0
- 8,684 shares0Common StockSEC:0001104659-23-041737:1
- 524 shares@ US$38.620.4% of flowCommon StockSEC:0001104659-23-039340:0
- 2,452 shares@ US$37.821.9% of flowCommon StockSEC:0001104659-23-037251:0
- 509 shares@ US$44.230.3% of flowCommon StockSEC:0001104659-23-030618:1
- 1,951 shares@ US$44.231.8% of flowCommon StockSEC:0001104659-23-030618:0
- 5,172 shares@ US$37.79274.3% of flowCommon StockSEC:0001415889-22-008738:1
- 12,894 shares@ US$37.040910.4% of flowCommon StockSEC:0001415889-22-008738:0
- 6,644 shares0Common StockSEC:0001415889-22-004408:0
- 1,878 shares@ US$29.911.2% of flowCommon StockSEC:0001415889-22-004022:0
- 337 shares@ US$29.690.2% of flowCommon StockSEC:0001415889-22-003968:0
25 of 64 declarations
